{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T19:53:06Z","timestamp":1789588386851,"version":"build-2803163510"},"reference-count":19,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2008,9,24]],"date-time":"2008-09-24T00:00:00Z","timestamp":1222214400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Transplant Infectious Dis"],"published-print":{"date-parts":[[2008,12]]},"abstract":"<jats:p><jats:bold>Background. <\/jats:bold>  <jats:italic>Nocardia<\/jats:italic> infection occurs in 2.1\u20133.5% of lung transplant recipients, and may involve cavitary nodular pulmonary lesions, soft tissue infection, or other sites of dissemination. Nocardiosis can pose challenging clinical problems in the areas of diagnosis and treatment. Diagnostic delays may occur, and adverse reactions to therapy are common. This study reviews clinical and epidemiological aspects of nocardiosis in lung transplant recipients, with special attention to pitfalls in management. Clinicians should be alert for these possibilities in order to institute prompt therapy and to achieve successful outcomes.<\/jats:p><jats:p><jats:bold>Methods. <\/jats:bold> A retrospective cohort study was conducted of 577 lung transplant recipients from January 1991 to May 2007. Demographics, reason for transplant, recent rejection, time from transplantation, site of infection, hypogammaglobulinemia, and\/or neutropenia shortly before onset, <jats:italic>Pneumocystis jiroveci<\/jats:italic> prophylaxis, <jats:italic>Nocardia<\/jats:italic> species, radiographic findings, extrapulmonary lesions, nature and duration of treatment, adverse reactions, and outcomes were recorded.<\/jats:p><jats:p><jats:bold>Result. <\/jats:bold>  <jats:italic>Nocardia<\/jats:italic> infection occurred in 1.9% (11\/577). Mean onset was 14.3 months after transplant (range 1.5\u201339 months). <jats:italic>N. asteroides<\/jats:italic> was isolated in 55% (6\/11). Emphysema was the most common reason for transplant (7\/11, 64%). Six patients were receiving trimethoprim\u2010sulfamethoxazole (TMP\u2010SMX) prophylaxis at the time of diagnosis. Three patients had immune globulin G levels &lt;400\u2003mg\/dL and 2 were neutropenic in the 3 months preceding diagnosis. Diagnosis was made by bronchoalveolar lavage (55%), skin abscess culture (18%), open lung biopsy (9%), pleural fluid (9%), and sputum culture (9%). Definitive diagnosis required a median of 9 days and a mean of 13.6 days (range 3\u201335 days) from the time of diagnostic sampling. Soft tissue lesions occurred in 3 and central nervous system involvement in 1 patient. Adverse reactions to therapy occurred in 9\/10 (90%) of patients for whom information was available. <jats:italic>Nocardia<\/jats:italic>\u2010related mortality occurred in 2\/11 patients (18%).<\/jats:p><jats:p><jats:bold>Conclusions. <\/jats:bold> Nocardiosis occurred in 1.9% of lung transplant recipients and was associated with a mean of nearly 2 weeks to diagnosis and frequent adverse effects on therapy. TMP\u2010SMX prophylaxis on a thrice weekly basis did not prevent all episodes of nocardiosis. Despite utilization of protocol bronchoscopies with cultures for <jats:italic>Nocardia<\/jats:italic>, this organism remains a source of clinical complexity in the lung transplant population.<\/jats:p>","DOI":"10.1111\/j.1399-3062.2008.00338.x","type":"journal-article","created":{"date-parts":[[2008,9,24]],"date-time":"2008-09-24T11:35:47Z","timestamp":1222256147000},"page":"403-408","source":"Crossref","is-referenced-by-count":63,"title":["Challenges in the diagnosis and management of <i>Nocardia<\/i> infections in lung transplant recipients"],"prefix":"10.1111","volume":"10","author":[{"given":"H.K.","family":"Poonyagariyagorn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Gershman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Avery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O.","family":"Minai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Blazey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Asamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Alster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Murthy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Mehta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Pettersson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.P.","family":"Mason","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Budev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2008,11,12]]},"reference":[{"key":"e_1_2_5_2_2","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/22.6.891"},{"issue":"10","key":"e_1_2_5_3_2","first-page":"47","article-title":"Nocardia infections","volume":"4","year":"2004","journal-title":"Am J Transplant"},{"key":"e_1_2_5_4_2","first-page":"2006","article-title":"Pulmonary nocardiosis in heart transplant recipients","volume":"35","author":"Peraira JR","year":"2003","journal-title":"treatment and outcome"},{"key":"e_1_2_5_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1053-2498(01)00394-1"},{"key":"e_1_2_5_6_2","first-page":"1307","article-title":"Risk factors, clinical characteristics, and outcome of Nocardia infection in organ transplant recipients","volume":"44","author":"Peleg AY","year":"2007","journal-title":"a matched case-control study"},{"key":"e_1_2_5_7_2","doi-asserted-by":"publisher","DOI":"10.1093\/clind\/16.4.505"},{"key":"e_1_2_5_8_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005792-198901000-00003"},{"key":"e_1_2_5_9_2","first-page":"492","article-title":"Nocardial infections in the immunocompromised host","volume":"3","author":"Simpson GL","year":"1981","journal-title":"a detailed study in a defined population"},{"key":"e_1_2_5_10_2","first-page":"11","article-title":"Nocardiosis in liver transplantation","volume":"20","author":"Forbes GM","year":"1990","journal-title":"variation in presentation, diagnosis and therapy"},{"key":"e_1_2_5_11_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-106-2-209"},{"key":"e_1_2_5_12_2","doi-asserted-by":"publisher","DOI":"10.1086\/318150"},{"key":"e_1_2_5_13_2","doi-asserted-by":"publisher","DOI":"10.1001\/archsurg.1997.01430270090019"},{"key":"e_1_2_5_14_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-82-1-18"},{"key":"e_1_2_5_15_2","first-page":"93","article-title":"Pulmonary nocardiosis in a heart transplant patient","volume":"26","author":"Haddad F","year":"2007","journal-title":"case report and review of the literature"},{"key":"e_1_2_5_16_2","doi-asserted-by":"publisher","DOI":"10.1128\/jcm.28.12.2726-2732.1990"},{"key":"e_1_2_5_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1053-2498(00)00119-4"},{"key":"e_1_2_5_18_2","first-page":"713","article-title":"Nocardia infection in patients with liver transplants or chronic liver disease","volume":"174","author":"Raby N","year":"1990","journal-title":"radiologic findings"},{"key":"e_1_2_5_19_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-200101270-00013"},{"key":"e_1_2_5_20_2","article-title":"Valganciclovir\u2010associated neutropenia in lung transplant recipients","author":"Githaiga A","year":"2006","journal-title":"Chest"}],"container-title":["Transplant Infectious Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1399-3062.2008.00338.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1399-3062.2008.00338.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,9]],"date-time":"2023-10-09T17:51:24Z","timestamp":1696873884000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1399-3062.2008.00338.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,11,12]]},"references-count":19,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2008,12]]}},"alternative-id":["10.1111\/j.1399-3062.2008.00338.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1399-3062.2008.00338.x","archive":["Portico"],"relation":{},"ISSN":["1398-2273","1399-3062"],"issn-type":[{"value":"1398-2273","type":"print"},{"value":"1399-3062","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,11,12]]}}}